Key facts
- This page summarizes William Gross's Form 4 filing for Heliogen, Inc. (HLGN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Feb 2024, 20:25.
William Gross - 15 Feb 2024 Form 4 Insider Report for Heliogen, Inc. (HLGN)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- HLGN
- Reported as of
- 15 Feb 2024
- Net transaction value
- -$672,072
- SEC form
- 4
- Accepted by SEC
- 20 Feb 2024, 20:25:26 UTC
- Prior SEC filing
- 20 Dec 2023
- Next SEC filing
- 15 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ William Gross
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William Gross filed Form 4 for Heliogen, Inc. (HLGN) on 20 Feb 2024.
Change
- Previous filing in this sequence was filed on 20 Dec 2023.
- Current net transaction value: -$672,072.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HLGN
transaction
Common Stock
Sale
- Transaction value
- $672,072
- Shares
- -442,298
- Change %
- -100%
- Price
- $1.52
- Shares after
- 0
- Date
- 15 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
HLGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 142,313
- Date
- 15 Feb 2024
- Ownership
- See footnote
- Footnotes
- F2
HLGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 462
- Date
- 15 Feb 2024
- Ownership
- See footnote
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Non-market, private transaction pursuant to a stock transfer between Idealab Holdings, LLC ("Idealab Holdings") and an affiliate of an existing holder of the Issuer's common stock. Price represents agreed value per share of non-cash consideration received in transfer. Idealab Holdings, which is a wholly owned subsidiary of Idealab, a California corporation ("Idealab"). Idealab is managed by a board of directors (the "Idealab Board") including Mr. Gross. Mr. Gross may be deemed to have beneficially own these shares. Mr. Gross disclaimed beneficial ownership of these shares except to the extent of his pecuniary interest therein. Stock transferred on 2/20/2024.
Footnote F2
These shares are held by The Gross Goodstein Living Trust (the "Trust") of which Mr. Gross is a co-trustee. Mr. Gross may be deemed to beneficially own these shares. Mr. Gross disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Footnote F3
These shares are held by Idealab Studio, LLC ("Idealab Studio"), for which Mr. Gross serves as chairman and chief executive officer. The Trust owns a majority of the class of securities of Idealab Studio entitled to elect two managers to Idealab Studio's board of managers. Mr. Gross may be deemed to beneficially own these shares. Mr. Gross disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.